| Date Filed | Type | Description |
| 06/16/2023 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/07/2023 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 580 shares
@ $38.339, valued at
$22.2k
|
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2022 |
4
| HASTINGS PAUL J (CEO) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Sold 6,126 shares
@ $13.0129, valued at
$79.7k
|
|
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| HASTINGS PAUL J (CEO) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 41,900 shares
@ $0
Granted 251,100 options to buy
@ $12.14, valued at
$3M
|
|
| 10/01/2021 |
4
| HASTINGS PAUL J (CEO) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Sold 8,277 shares
@ $27.2, valued at
$225.1k
Sold 223 shares
@ $26.53, valued at
$5.9k
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| HASTINGS PAUL J (See Remarks) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 202,400 options to buy
@ $18, valued at
$3.6M
|
|
| 07/09/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/11/2020 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,260 shares
@ $0
Granted 8,027 options to buy
@ $47.65, valued at
$382.5k
|
|
| 06/08/2020 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 2,025 shares
@ $47.46, valued at
$96.1k
|
|
| 06/06/2019 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Sold 782 shares
@ $42.66, valued at
$33.4k
Granted 4,134 shares
@ $0
Granted 8,437 options to buy
@ $43.54, valued at
$367.3k
|
|
| 06/15/2018 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Granted 782 shares
@ $0
Granted 4,693 options to buy
@ $38.35, valued at
$180k
|
|
| 06/11/2018 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 12,700 options to buy
@ $2.5, valued at
$31.8k
|
|
| 06/06/2018 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Sold 771 shares
@ $33.9, valued at
$26.1k
|
|
| 10/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2017 |
4
| HASTINGS PAUL J (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Granted 1,357 shares
@ $0
Granted 2,714 options to buy
@ $44.2, valued at
$120k
|
|
| 04/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|